 "Astec Lifesciences rallies over 35% in two trading sessions post Q2 results")
Astec Lifesciences has rallied 16% to Rs 629, extending its Friday’s 20% surge on BSE, after the company reported more than five-fold jump in consolidated net profit at Rs 11.18 crore for the quarter ended September 30, 2016 (Q2FY17). The agrochemicals company had profit of Rs 2.02 crore in the same quarter year ago.
Total income from operations grew 30% at Rs 90 crore during the quarter under review against Rs 69 crore in the corresponding quarter of previous fiscal.
EBITDA (earnings before interest, taxes, depreciation, and amortization) margin improved to 25.9% from 14.77%.
At 06:39 pm, the stock was up 14% at Rs 622 on BSE, as compared to 0.21% rise in the S&P BSE Sensex.
The trading volumes on the counter more than doubled with a combined 334,222 shares changed hands on BSE and NSE so far.
Total income from operations grew 30% at Rs 90 crore during the quarter under review against Rs 69 crore in the corresponding quarter of previous fiscal.
EBITDA (earnings before interest, taxes, depreciation, and amortization) margin improved to 25.9% from 14.77%.
At 06:39 pm, the stock was up 14% at Rs 622 on BSE, as compared to 0.21% rise in the S&P BSE Sensex.
The trading volumes on the counter more than doubled with a combined 334,222 shares changed hands on BSE and NSE so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%